Navigation Links
Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition
Date:9/28/2010

NEW YORK, Sept. 28 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition

http://www.reportlinker.com/p0304775/Global-In-Vitro-Diagnostics-IVD-Market-Report-2010-Edition.html

The global IVD market has been experiencing rapid growth, in spite of the economic recession. There has been growing awareness about health and prevention of diseases among the people, which is expected to further boost the industry's performance in the coming years. Furthermore, with countries making their healthcare services more and more accessible to the people, the demand for various IVD devices is increasing.

The developed countries presently account for the bulk of the IVD market. The emerging economies although do not have a major share in the global market, but are expected to grow at faster rate in the future and offer growth opportunities in the global market. The US, Europe and Japan are the main markets for both the pharmaceuticals and IVD industries, controlling more than three-fourth of the global IVD market. In Europe, the largest markets are Germany, followed by Italy and France.

Diabetes has been one of the major segments of the IVD market. Also, diabetes is regarded as one of the fastest growing diseases in the world due to the changing lifestyle of the present era's population.

Demand within the IVD industry has been driven by the ever increasing ageing population, technological advancements and more strict disease control standards in developed countries, amongst others. The emerging economies offer immense opportunities for the further growth of the industry. The increasing insurance facilities are also expected to boost the growth of the industry in the coming years. Complying with the laws and regulations has been one of the major challenges faced by the industry.

The global IVD market has been highly consolidated, with the top eight players accounting for a major share of the market. Roche Holdings is the market leader controlling a major part of the market.

The report analysis the IVD market on a global scale and it also provides detailed information regarding the key regional markets, Europe, US as well as the one of the emerging economies, India. The report analyses the various trends and challenges being faced by the global IVD market. It profiles the four major Pharma players involved in IVD testing: Roche Holdings, Siemens AG, Abbott Laboratories and Beckman Coulter.

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

1. Diagnostics Market

1.1 Overview

1.2 In Vitro Diagnostic

IVD Process

IVD End Users

2. Global IVD Market

Market Value & Growth Rate

Breakdown by Region

Market Segmentation

Key Players by Segments

3. IVD Market - Country Analysis

3.1 Mature Markets

3.1.1 European IVD Market

Market Value

Breakdown by Countries

3.1.2 United States IVD Market

Market Value

Market Segmentation

3.2 Emerging Market

3.2.1 India

Overview

Market Segmentation

4. Market Trends and Drivers

4.1 Market Trends

4.1.1 Industry Consolidation

4.2 Growth Drivers

4.2.1 Ageing Population Worldwide

4.2.2 Demand from the Emerging Economies

4.2.3 Strict Disease Control Standards in Developed Countries

4.2.3 Technological Advancement

4.2.4 Diabetic Population

4.2.5 Increasing Insurance Density

5. Key Challenges

5.1 Stringent Regulations

5.2 Launch of New Products

6. IVD Market - Competitive Landscape

Market Share

Financial Comparison – Revenue, EBIT, Net Margin & EPS

7. Company Profiles

7.1 Roche Holdings AG

Company Overview

Key Financials

Business Strategies

Innovation in Therapeutics & Diagnostics

Personalized Healthcare

7.2 Siemens AG

Company Overview

Key Financials

Business Strategies

Focus on Innovation

Trendsetter in Imaging

7.3 Abbott Laboratories

Company Overview

Key Financials

Business Strategies

Diverse Mix of Business Portfolio

Mergers & Acquisitions

7.4 Beckman Coulter

Company Overview

Key Financials

Business Strategies

Strategic Acquisitions

Expansion of Geographic Reach

8. Market Outlook

8.1 Market Forecast

8.2 Forecast Methodology

8.2.1 Dependent and Independent Variables

8.2.2 Correlation Analysis

8.2.3 Regression Analysis

List of ChartsGlobal IVD Market – Segments by Technology

In Vitro Diagnostics (IVD) Process

IVD Market – End Users

Global IVD Market Size (2002-2009)

Geographical Breakdown of Global Clinical IVD Market (2008)

IVD Growth Rates by Region (2009-2014)

Global IVD Market Segmentation by Technology (2009)

Global IVD Market by Clinical Segments (2008E)

IVD Testing By End User (2008)

IVD Market Size of European Countries (2008)

Vitamin D Penetration per 1000 Inhabitants in Europe (2009)

Vitamin D Market Penetration and Tests in Europe (2009 and 2014)

US Healthcare Expenditure (2001-2009E)

US Diagnostic Testing Market Size by Revenue (2008)

Vitamin D Market Penetration and Tests in the US (2009 and 2014)

Indian IVD Market Segmentation (2007)

India Reagents Market by Segments (2008E)

Ageing Population Worldwide (age>65) 2005-2015

World Population with Diabetes, Age Group 20-79 year (2006-2012)

Global Insurance Density (2003-2009)

Global IVD Market Share by Company (2008)

IVD Market Competitors by Diagnostic Revenue (2008)

IVD Market Competitors Diagnostic Divisional EBIT Margin

Roche Holdings Revenue (2005-2009)

Roche Holdings Revenue by Segments (2009)

Siemens AG Revenue (20055-2009)

Siemens Revenue Breakdown by Segments (2009)

Abbott Laboratories Revenue (2005-2009)

Abbott Laboratories Revenue by Segments (2009)

Beckman Coulter Revenue (2005-2009)

Beckman Coulter Revenue Breakdown by Segments (2009)

Global In Vitro Diagnostic Market in GBP billion (2009-2014E)

Global In Vitro Diagnostics Market in US$ billion (2009-2014E)

List of TablesContributions of IVD

Top 10 Regional IVD Markets (2008 and 2015E)

Global IVD Market by Country (2002-2012E)

IVD Market Key Players by Segments

Country-wise Division of European IVD Market (2008)

Financial Position of Key Players (FY09)

Growth Rates of Key Players (2009-2011E)

Dependent & Independent Variables (2003– 2009)

Correlation Matrix

Model Summary – Coefficient of Determination

Regression Coefficients Output

To order this report:In Vitro Diagnostic Industry: Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition

In Vitro Diagnostic Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!CONTACT:Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Global Pico Projector By Application, Technology & Products Market (2010-2014)
2. Reportlinker Adds Top 10 Drug Delivery Technologies (2010 - 2015)
3. Reportlinker Adds Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
4. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
5. Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile
6. Reportlinker Adds Genzyme Corporation: PharmaVitae Profile
7. Reportlinker Adds Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets
8. Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets
9. Reportlinker Adds Actelion Ltd: PharmaVitae Profile
10. Reportlinker Adds Pfizer Inc.: PharmaVitae Profile
11. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... BUDAPEST , Ungarn, February 12, 2016 ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ... gab heute positive Ergebnisse seines klinischen Forschungsprogramms ... und Asthma-Patienten beschäftigt, ergab Verbesserungen ihrer respiratorischen ... Indiso ltd , ein Medizintechnikunternehmen, das ...
(Date:2/11/2016)... , Feb. 11, 2016 Stem cells are ... characterized by self-renewal and the capacity to differentiate into ... new discovery, as the first mouse embryonic stem cells ... not until 1995 that the first culturing of embryonic ... cells were not produced until 2006 As a result ...
(Date:2/11/2016)... , Feb. 11, 2016  Walgreens has committed to ... states and Washington, D.C. as part ... that was commended by shareholder advocacy organization As You Sow. ... You Sow. "Many people hold on to unneeded drugs because ... have tragic consequences." --> Conrad MacKerron , ...
Breaking Medicine Technology:
(Date:2/11/2016)... Angeles, CA (PRWEB) , ... February 11, 2016 , ... ... Loss System, a product marketed as a weight loss dietary supplement, is being recalled ... medical group Beverly Hills Physicians, because there is not a single supplement on the ...
(Date:2/11/2016)... ... ... Registered nurses, licensed practical nurses and nursing aides who treat stroke patients ... to Heal” on Thursday, February 25 from 9:00 to 11:00 a.m. at the ... of ANSA Consultants, who will discuss clinical best practices throughout the continuum of stroke ...
(Date:2/11/2016)... ... ... The Journal of Pain Research has seen a significant increase in ... from the Scopus database (Elsevier B.V.) and is a measure of a journal's impact. ... a three year period and also the importance of the journals where the citations ...
(Date:2/11/2016)... IL (PRWEB) , ... February 11, 2016 , ... ... to the healthcare industry, ranked among the top five firms in the “2015/2016 ... and HIT Implementation Support and Staffing. KLAS is a research and insights firm ...
(Date:2/11/2016)... ... February 11, 2016 , ... Thermi™, a world leader in ... announce the promotions of Allison Kelly to executive vice president of the company’s ... president of North American capital sales, and Wendy Oseas to vice president of ...
Breaking Medicine News(10 mins):